COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1203
https://www.valueinhealthjournal.com/article/S1098-3015(15)03279-9/fulltext
Title : COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03279-9&doi=10.1016/j.jval.2015.09.1203
First page : A463
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 708
Categories :
Tags :
Regions :
ViH Article Tags :